Phosphoinositidase C beta 1 isoform expression is modulated by interferon alpha in Burkitt lymphoma cells

A Cataldi1, R Di Pietro, A Antonucci

  • 1Istituto di Morfologia Umana Normale, Facoltà di Medicina e Chirurgia, Chieti, Italy.

Cellular Signalling
|February 1, 1995
PubMed

Insights

Interferon treatment alters phosphoinositidase C (PIC) beta 1 expression in the nucleus of Burkitt lymphoma cells, suggesting distinct signal transduction pathways. This impacts the inositol lipid cycle, influencing cell proliferation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Phosphoinositidase C (PIC) enzymes play critical roles in cellular signaling pathways.
  • Interferon is known to modulate cellular processes, including proliferation and immune responses.
  • Understanding the localization and regulation of PIC isozymes is crucial for deciphering signal transduction.

Purpose of the Study:

  • To investigate the expression and localization of phosphoinositidase C (PIC) beta 1, gamma 1, and delta 1 isozymes in Burkitt lymphoma cells.
  • To determine the effect of interferon treatment on PIC isozyme expression and localization.
  • To elucidate the role of PIC isozymes in interferon-mediated signal transduction and antiproliferative effects.

Main Methods:

  • Western blotting and immunocytochemical analysis were employed.
  • Specific monoclonal antibodies against PIC beta 1, gamma 1, and delta 1 isozymes were used.
  • Control and interferon-treated Burkitt lymphoma cells were analyzed.

Main Results:

  • PIC beta 1 was primarily detected in the nucleus and showed transient modifications after interferon treatment.
  • PIC delta 1 was found only in the cytoplasm and appeared insensitive to interferon.
  • PIC gamma 1 was detected at low levels or not at all in both cytoplasmic and nuclear compartments.

Conclusions:

  • Interferon's antiproliferative effect may involve at least two distinct signal transduction pathways at cytoplasmic and nuclear levels.
  • The inositol lipid cycle, particularly through nuclear PIC beta 1 modulation, is implicated in interferon's action.
  • PIC beta 1's nuclear localization and regulation are key to understanding interferon's cellular effects.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...